The Duke Clinical Research Institute (DCRI) has been named the Clinical Trials Data Coordinating Center for large-scale national research studies aimed at understanding and improving the treatment of long COVID.

Although typically classified as a single ethnic group, people of Hispanic heritage have markedly different risks for brain tumors based on their geographic origins, suggesting greater diversity that warrants attention in the health care setting.

This summer, eight scholars from across the country were paired with a faculty research mentor to learn laboratory skills, designing a research project, and effectively presenting future research.

The fellowship program aims to build a community committed to advancing science through diversity and inclusion.

Murali Doraiswamy, M.B.B.S., sat down with Robert Califf, M.D., commissioner of the Food and Drug Administration (FDA) and the two discussed a range of issues, focusing on potential opportunities to enhance psychiatric care and support patients.

Liping Feng M.D., an associate professor of obstetrics and gynecology and affiliate of the Duke Global Health Institute, wants to know whether toxic environmental exposures increase the number of cases of preeclampsia, a serious, potentially life-threatening complication during pregnancy.

Antoinette Jasmine Charles, a second-year medical student, has already built an impressive record of social justice, activism, and civic service. This summer she was invited to join the White House Health Equity Leaders Roundtable Series, a series of discussions among medical students, clinicians, and policymakers focused on issues including access to care and social determinants of health.

Suzanne Barbour, a biochemist and national leader in graduate education, has been appointed dean of The Graduate School and vice provost for graduate education, Provost Sally Kornbluth announced Monday. Barbour will also hold a faculty appointment in the Duke University School of Medicine.

In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.